A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs

Name: A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs
Published: 2021
License: Public Domain

Bristol-Myers Squibb · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

psoriatic-arthritis

psoriatic arthritis, biologic-naive, bms-986165, deucravacitinib, disease-modifying anti-rheumatic drugs, dmards, joint disease, psa, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs

Related documents